Literature DB >> 14970830

Identification of genes regulated by memantine and MK-801 in adult rat brain by cDNA microarray analysis.

Markéta Marvanová1, Merja Lakso, Garry Wong.   

Abstract

In this study, we monitored gene expression profiles using cDNA microarrays after an acute systemic administration of the high affinity N-methyl-D-aspartate (NMDA) uncompetitive antagonist MK-801 (1 mg/kg; 4 h), and the clinically used moderate affinity antagonist memantine (25 mg/kg; 4 h) in adult rat brains. From a microarray containing 1090 known genes, 13 genes were regulated by both treatments of which 12 were upregulated and one was downregulated. In addition, 28 and 34 genes were regulated (> or = 1.5- or < or = 0.67-fold change) by either memantine or MK-801, respectively. Genes commonly regulated by both treatments and not previously reported were confirmed by in situ hybridization (ISH) and include regenerating liver inhibitory factor-1 (RL/IF-1), GDP-dissociation inhibitor 1 (GDI-1), neural visinin Ca2+-binding protein 2 (NVP-2), neuromedin B receptor, and Na+/K+ transporting ATPase 2beta. ISH with memantine (5-50 mg/kg) revealed regulation of these genes in other cortical and hippocampal regions. RL/IF-1 induction occurred at 1 h and returned to basal levels by 8 h, consistent with the profile of an immediate early gene. Western blot analysis showed increases (approximately 30-65%) in GDI-1 protein present in both cytosolic and membrane fractions that were significant in the 84-kDa Rab bound form, suggesting that memantine influences Ras-like GTPase function. Genes regulated by a 5 mg/kg dose of memantine might be important in its therapeutic effects. These findings increase the number of known, differentially altered genes after treatment of uncompetitive NMDA receptor antagonists and suggest broader actions of these agents than previously realized. Copyright 2004 Nature Publishing Group

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14970830     DOI: 10.1038/sj.npp.1300398

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  11 in total

1.  DNA microarray unravels rapid changes in transcriptome of MK-801 treated rat brain.

Authors:  Yuka Kobayashi; Sofya P Kulikova; Junko Shibato; Randeep Rakwal; Hiroyuki Satoh; Didier Pinault; Yoshinori Masuo
Journal:  World J Biol Chem       Date:  2015-11-26

2.  Efficacy of local polymer-based and systemic delivery of the anti-glutamatergic agents riluzole and memantine in rat glioma models.

Authors:  Kaleb Yohay; Betty Tyler; Kyle D Weaver; Andrea C Pardo; Dan Gincel; Jaishri Blakeley; Henry Brem; Jeffrey D Rothstein
Journal:  J Neurosurg       Date:  2014-01-31       Impact factor: 5.115

3.  Abnormalities of neurotransmitter and neuropeptide systems in human neuroepithelioma cells infected by three Toxoplasma strains.

Authors:  Jianchun Xiao; Ye Li; Lorraine Jones-Brando; Robert H Yolken
Journal:  J Neural Transm (Vienna)       Date:  2013-07-03       Impact factor: 3.575

4.  Differential effects of three canonical Toxoplasma strains on gene expression in human neuroepithelial cells.

Authors:  Jianchun Xiao; Lorraine Jones-Brando; C Conover Talbot; Robert H Yolken
Journal:  Infect Immun       Date:  2010-12-13       Impact factor: 3.441

5.  Gene expression profiling in rodent models for schizophrenia.

Authors:  Jessica E Van Schijndel; Gerard J M Martens
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

6.  Testes and brain gene expression in precocious male and adult maturing Atlantic salmon (Salmo salar).

Authors:  Aoife Guiry; Denis Flynn; Sophie Hubert; Allan M O'Keeffe; Olivier LeProvost; Samantha L White; Patrick F Forde; Pamela Davoren; Benoit Houeix; Terry J Smith; Deirdre Cotter; Noel P Wilkins; Michael T Cairns
Journal:  BMC Genomics       Date:  2010-03-30       Impact factor: 3.969

7.  Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.

Authors:  M Ayalew; H Le-Niculescu; D F Levey; N Jain; B Changala; S D Patel; E Winiger; A Breier; A Shekhar; R Amdur; D Koller; J I Nurnberger; A Corvin; M Geyer; M T Tsuang; D Salomon; N J Schork; A H Fanous; M C O'Donovan; A B Niculescu
Journal:  Mol Psychiatry       Date:  2012-05-15       Impact factor: 15.992

8.  Memantine-induced Myoclonus in a Patient with Alzheimer Disease.

Authors:  Aditya A Murgai; Mark S LeDoux
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-08-14

9.  Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11.

Authors:  Delphine Vandame; Lauriane Ulmann; Marisa Teigell; Monica Prieto-Cappellini; Jacques Vignon; Alain Privat; Regino Perez-Polo; Olivera Nesic; Helene Hirbec
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

10.  Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action.

Authors:  Joanna Ficek; Magdalena Zygmunt; Marcin Piechota; Dzesika Hoinkis; Jan Rodriguez Parkitna; Ryszard Przewlocki; Michal Korostynski
Journal:  BMC Genomics       Date:  2016-05-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.